Ignite Creation Date:
2025-12-25 @ 1:34 AM
Ignite Modification Date:
2026-03-05 @ 4:54 PM
Study NCT ID:
NCT04684394
Status:
TERMINATED
Last Update Posted:
2022-10-31
First Post:
2020-12-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Neovascular Age-related Macular Degeneration
Sponsor:
Gemini Therapeutics, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-29
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-02-18
Completion Date Type:
ACTUAL
First Submit Date:
2020-12-21
First Submit QC Date:
None
Study First Post Date:
2020-12-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-10-04
Results First Submit QC Date:
None
Results First Post Date:
2022-10-31
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-04
Last Update Post Date:
2022-10-31
Last Update Post Date Type:
ACTUAL